Download presentation
Presentation is loading. Please wait.
Published byErnest Simpson Modified over 8 years ago
1
Long Term Outcomes of Aortic Root Operations for Marfan Syndrome: A Comparison of Bentall versus Aortic Valve-Sparing Procedures Joel Price, MD, J. Trent Magruder, MD, Allen Young, MPH, Joshua C. Grimm, MD, Nishant D. Patel, MD, Diane Alejo, Luca A. Vricella, MD, and Duke E. Cameron, MD From the Division of Cardiac Surgery, Department of Surgery, Johns Hopkins University, Baltimore, Maryland 2015 AATS Annual meeting
2
No disclosures
3
Background Marfan Syndrome: –autosomal dominant condition FBN1 gene, incidence of 1 in 3000-5000 –Aortic root dilation most common feature, part of diagnostic criteria –Dismal natural history, aortic dissection and death Prophylactic aortic root replacement in Marfan syndrome improves survival
4
Background Mechanical Composite Valve-GraftAortic Valve Sparring Root Replacement
5
Background Optimal procedure unknown –Bentall versus valve-sparing root replacement (VSRR) Little published data on long-term comparative outcomes
6
Johns Hopkins experience
7
Objectives To compare long-term clinical and valve-related outcomes of Marfan patients undergoing aortic root replacement with mechanical valve-graft or VSRR
8
Methods Adult MFS patients undergoing mechanical composite valve-graft replacement or VSRR procedures 1997 – 2014 Comprehensive follow-up from records and telephone interview Outcomes: Survival, thromboembolism/ hemorrhage, AV endocarditis, aortic valve/root reoperation Statistics: T-tests/chi2/rank-sum tests, Time-to-event analysis, Cox proportional hazards modeling with propensity score adjustment
9
Results
10
Baseline characteristics BentallVSRRp N = 1656798- Median age (IQR)37 (31-50)36 (29-41)0.03 Male sex (%)40 (61.5)66 (72.5)0.17 Median sinus diameter (cm) (IQR) 5.5 (5.0-6.0)5.0 (4.9-5.3)0.003 Bicuspid valve (%) 5 (7.4)2 (2.1)0.20 Aortic dissection (%) 17 (25.4)4 (4.1)<0.001 3+/4+ AI (%) 33 (49.3)14 (14.4)<0.001 Urgent/emergent operation (%) 16 (24.6)3 (3.3)<0.001
11
Baseline characteristics BentallVSRRp N = 1656798- Median age (IQR)37 (31-50)36 (29-41)0.03 Male sex (%)40 (61.5)66 (72.5)0.17 Median sinus diameter (cm) (IQR) 5.5 (5.0-6.0)5.0 (4.9-5.3)0.003 Bicuspid valve (%) 5 (7.4)2 (2.1)0.20 Aortic dissection (%) 17 (25.4)4 (4.1)<0.001 3+/4+ AI (%) 33 (49.3)14 (14.4)<0.001 Urgent/emergent operation (%) 16 (24.6)3 (3.3)<0.001
12
Baseline characteristics BentallVSRRp N = 1656798- Median age (IQR)37 (31-50)36 (29-41)0.03 Male sex (%)40 (61.5)66 (72.5)0.17 Median sinus diameter (cm) (IQR) 5.5 (5.0-6.0)5.0 (4.9-5.3)0.003 Bicuspid valve (%) 5 (7.4)2 (2.1)0.20 Aortic dissection (%) 17 (25.4)4 (4.1)<0.001 3+/4+ AI (%) 33 (49.3)14 (14.4)<0.001 Urgent/emergent operation (%) 16 (24.6)3 (3.3)<0.001
13
Baseline characteristics BentallVSRRp N = 1656798- Median age (IQR)37 (31-50)36 (29-41)0.03 Male sex (%)40 (61.5)66 (72.5)0.17 Median sinus diameter (cm) (IQR) 5.5 (5.0-6.0)5.0 (4.9-5.3)0.003 Bicuspid valve (%) 5 (7.4)2 (2.1)0.20 Aortic dissection (%) 17 (25.4)4 (4.1)<0.001 3+/4+ AI (%) 33 (49.3)14 (14.4)<0.001 Urgent/emergent operation (%) 16 (24.6)3 (3.3)<0.001
14
Baseline characteristics BentallVSRRp N = 1656798- Median age (IQR)37 (31-50)36 (29-41)0.03 Male sex (%)40 (61.5)66 (72.5)0.17 Median sinus diameter (cm) (IQR) 5.5 (5.0-6.0)5.0 (4.9-5.3)0.003 Bicuspid valve (%) 5 (7.4)2 (2.1)0.20 Aortic dissection (%) 17 (25.4)4 (4.1)<0.001 3+/4+ AI (%) 33 (49.3)14 (14.4)<0.001 Urgent/emergent operation (%) 16 (24.6)3 (3.3)<0.001
15
Baseline characteristics BentallVSRRp N = 1656798- Median age (IQR)37 (31-50)36 (29-41)0.03 Male sex (%)40 (61.5)66 (72.5)0.17 Median sinus diameter (cm) (IQR) 5.5 (5.0-6.0)5.0 (4.9-5.3)0.003 Bicuspid valve (%) 5 (7.4)2 (2.1)0.20 Aortic dissection (%) 17 (25.4)4 (4.1)<0.001 3+/4+ AI (%) 33 (49.3)14 (14.4)<0.001 Urgent/emergent operation (%) 16 (24.6)3 (3.3)<0.001
16
Operative data BentallVSRRp Reimplantation- 69 (70.4) - Remodeling- 29 (29.6) - CPB time 158.8143.60.08 Cross-clamp time 111.6104.20.25 Concomitant procedures PFO/ASD closure 18 (26.9)43 (44.3)0.03 MV repair 2 (3.0)7 (7.2)0.31 MV replacement 4 (6.0)00.03 CABG 6 (9.0)2 (2.1)0.06
17
Operative data BentallVSRRp Reimplantation- 69 (70.4) - Remodeling- 29 (29.6) - CPB time 158.8143.60.08 Cross-clamp time 111.6104.20.25 Concomitant procedures PFO/ASD closure 18 (26.9)43 (44.3)0.03 MV repair 2 (3.0)7 (7.2)0.31 MV replacement 4 (6.0)00.03 CABG 6 (9.0)2 (2.1)0.06
18
Operative data BentallVSRRp Reimplantation- 69 (70.4) - Remodeling- 29 (29.6) - CPB time 158.8143.60.08 Cross-clamp time 111.6104.20.25 Concomitant procedures PFO/ASD closure 18 (26.9)43 (44.3)0.03 MV repair 2 (3.0)7 (7.2)0.31 MV replacement 4 (6.0)00.03 CABG 6 (9.0)2 (2.1)0.06
19
Short-term outcomes BentallVSRRp In-hospital death 001.00 Pneumothorax 6 (9.0)7 (7.1)0.77 Hemothorax 2 (3.0)1 (1.0)0.57 Reoperation for bleeding 1 (1.5)2 (2.0)1.00 Atrial fibrillation 14 (20.9)19 (19.4)0.85
20
Long-term outcomes
21
Survival by procedure type
22
Freedom from thromboembolic events
23
Freedom from hemorrhagic events
24
Freedom from composite outcome
25
Freedom from aortic valve endocarditis
26
Freedom from aortic valve/root reoperation
27
Sub-group analysis Reimplantation vs Remodelling
28
Freedom from aortic valve/root reoperation
29
Freedom from moderate/severe AI
30
Limitations Retrospective study; method of repair chosen at time of operation Relatively small sample size
31
Conclusions VSRR has a significantly decreased risk of composite thromboembolic/hemorrhagic events as compared to Bentall procedures Survival and freedom from endocarditis were similar in both procedure types VSRR has similar durability compared to Bentall procedures Reimplantation VSRR should continue to play an important role in the treatment of well-selected patients with MFS
32
2015 AATS Annual meeting Thank you
33
Results – late events Bentall (n=67) VSRR (n=98) Log rank p Ten-year survival 90.5%96.3%0.10 Deaths 63 Linearized event rate (%/yr) 1.23%0.41% Ten-year freedom from thromboembolism/hemorhage 77.6%96.7%< 0.001 Thromboembolic/hemorrhagic events 154 Linearized event rate (%/yr) 3.50%0.55% Ten-year freedom from AV/root reoperation 92.0%92.9%0.52 AV/root reoperations 44 Linearized event rate (%/yr) 0.86%0.56% Ten-year freedom from endocarditis 91.7%98.9%0.14 Endocarditis events 31 Linearized event rate (%/yr) 0.17%0.04%
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.